Eledon Pharmaceuticals, Inc.
ELDN
$2.62
$0.0451.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.56M | 4.53M | 6.46M | 4.09M | 4.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.73M | 17.96M | 24.70M | 20.51M | 14.50M |
| Operating Income | -24.73M | -17.96M | -24.70M | -20.51M | -14.50M |
| Income Before Tax | -11.22M | -6.50M | -44.19M | 76.97M | -44.91M |
| Income Tax Expenses | -- | -- | 431.00K | -- | -- |
| Earnings from Continuing Operations | -11.22M | -6.50M | -44.62M | 76.97M | -44.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.22M | -6.50M | -44.62M | 76.97M | -44.91M |
| EBIT | -24.73M | -17.96M | -24.70M | -20.51M | -14.50M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.15 | -0.08 | -0.60 | 1.05 | -1.06 |
| Normalized Basic EPS | -0.09 | -0.05 | -0.40 | 0.93 | -0.66 |
| EPS Diluted | -0.15 | -0.08 | -0.60 | -0.32 | -1.06 |
| Normalized Diluted EPS | -0.09 | -0.05 | -0.40 | 0.87 | -0.66 |
| Average Basic Shares Outstanding | 77.16M | 77.13M | 69.85M | 51.95M | 42.28M |
| Average Diluted Shares Outstanding | 77.16M | 77.13M | 69.85M | 55.48M | 42.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |